Huang Hao, Zang Yu-Jie, Li Zheng-Guo, Li Qian, Ma Chun-Yan, Zhao Hai-Yuan, Li Hang
Department of Laboratory Medicine and Key Laboratory of Tumor Marker Detection, Kaifeng Central Hospital, Kaifeng, Henan, China.
Front Immunol. 2025 May 16;16:1593577. doi: 10.3389/fimmu.2025.1593577. eCollection 2025.
To investigate the impact of SARS-CoV-2 infection on the formation of antineutrophil cytoplasmic antibodies (ANCA).
Serum samples from 154 patients infected with SARS-CoV-2 were collected and tested for ANCA and antinuclear antibodies (ANA) using indirect immunofluorescence assay (IFA). Enzyme-linked immunosorbent assay (ELISA) was used to confirm the target antigens in ANCA fluorescence-positive samples. Eighty-seven healthy individuals were selected as the control group. Statistical analysis was performed using SPSS 26.0 software, with P < 0.05 considered statistically significant.
The ANCA fluorescence positivity rate in the control group (1.1%) was not significantly different from that in COVID-19 positive patients (2.5%) (χ² = 0.574, P > 0.05). Among COVID-19 positive patients, 4 cases (2.5%) were ANCA fluorescence positive, while 10 cases (6.4%) were ANA positive. The difference between these two rates was not statistically significant (χ² = 2.694, P > 0.05).
The Omicron variant of SARS-CoV-2 has minimal association with the formation of serum ANCA.
探讨严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染对抗中性粒细胞胞浆抗体(ANCA)形成的影响。
收集154例SARS-CoV-2感染患者的血清样本,采用间接免疫荧光法(IFA)检测ANCA和抗核抗体(ANA)。酶联免疫吸附试验(ELISA)用于确认ANCA荧光阳性样本中的靶抗原。选取87名健康个体作为对照组。使用SPSS 26.0软件进行统计分析,P<0.05认为具有统计学意义。
对照组的ANCA荧光阳性率(1.1%)与新冠病毒病(COVID-19)阳性患者的阳性率(2.5%)无显著差异(χ² = 0.574,P>0.05)。在COVID-19阳性患者中,4例(2.5%)ANCA荧光阳性,10例(6.4%)ANA阳性。这两个比率之间的差异无统计学意义(χ² = 2.694,P>0.05)。
SARS-CoV-2的奥密克戎变异株与血清ANCA的形成关联极小。